Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Frontiers in Cell and Developmental Biology|November 6, 2023
The RNA binding proteins <i>ZFP36L1</i> and <i>ZFP36L2</i> are dysregulated in airway epithelium in human and a murine model of asthmaJennifer Rynne, Elena Ortiz-Zapater, Dustin C Bagley, et al.
The Lancet. Respiratory Medicine|December 10, 2023
Pioneering a paradigm shift in asthma management: remission as a treatment goalMarek Lommatzsch, Roland Buhl, G Walter Canonica, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2021
Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert OpinionRoland Buhl, Elisabeth Bel, Arnaud Bourdin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2015
Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbationsDavid J Jackson, Nicholas Glanville, Maria-Belen Trujillo-Torralbo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2025
Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma RegistryP Jane McDowell, Charlene Redmond, John Busby, et al.
Journal of Asthma and Allergy|June 26, 2024
Healthcare Resource Utilization Associated with Intermittent Oral Corticosteroid Prescribing Patterns in AsthmaTrung N Tran, Heath Heatley, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 25, 2024
Preserved antibody responses to COVID-19 vaccination and lower odds of developing COVID-19 in adults with severe asthmaHitasha Rupani, Diane Edwards, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2021
Factors Associated with Frequent Exacerbations in the UK Severe Asthma RegistryFreda Yang, John Busby, Liam G Heaney, et al.
Ebiomedicine|April 13, 2020
M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbationsAlexandra Nikonova, Musa Khaitov, David J Jackson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 25, 2022
Type I conventional dendritic cells relate to disease severity in virus-induced asthma exacerbationsAoife Cameron, Jaideep Dhariwal, Nadine Upton, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Frontiers in Cell and Developmental Biology|November 6, 2023
The RNA binding proteins <i>ZFP36L1</i> and <i>ZFP36L2</i> are dysregulated in airway epithelium in human and a murine model of asthmaJennifer Rynne, Elena Ortiz-Zapater, Dustin C Bagley, et al.
The Lancet. Respiratory Medicine|December 10, 2023
Pioneering a paradigm shift in asthma management: remission as a treatment goalMarek Lommatzsch, Roland Buhl, G Walter Canonica, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 11, 2021
Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert OpinionRoland Buhl, Elisabeth Bel, Arnaud Bourdin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 4, 2015
Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbationsDavid J Jackson, Nicholas Glanville, Maria-Belen Trujillo-Torralbo, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 7, 2025
Observational Analysis of Biological Remission as a Treatment Target for Severe Asthma: UK Severe Asthma RegistryP Jane McDowell, Charlene Redmond, John Busby, et al.
Journal of Asthma and Allergy|June 26, 2024
Healthcare Resource Utilization Associated with Intermittent Oral Corticosteroid Prescribing Patterns in AsthmaTrung N Tran, Heath Heatley, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 25, 2024
Preserved antibody responses to COVID-19 vaccination and lower odds of developing COVID-19 in adults with severe asthmaHitasha Rupani, Diane Edwards, Rekha Chaudhuri, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2021
Factors Associated with Frequent Exacerbations in the UK Severe Asthma RegistryFreda Yang, John Busby, Liam G Heaney, et al.
Ebiomedicine|April 13, 2020
M1-like macrophages are potent producers of anti-viral interferons and M1-associated marker-positive lung macrophages are decreased during rhinovirus-induced asthma exacerbationsAlexandra Nikonova, Musa Khaitov, David J Jackson, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 25, 2022
Type I conventional dendritic cells relate to disease severity in virus-induced asthma exacerbationsAoife Cameron, Jaideep Dhariwal, Nadine Upton, et al.
Pageof 19